In:
PLOS ONE, Public Library of Science (PLoS), Vol. 16, No. 7 ( 2021-7-2), p. e0252874-
Abstract:
Filoviruses (Family Filoviridae genera Ebolavirus and Marburgvirus ) are negative-stranded RNA viruses that cause severe health effects in humans and non-human primates, including death. Except in outbreak settings, vaccines and other medical countermeasures against Ebola virus (EBOV) will require testing under the FDA Animal Rule. Multiple vaccine candidates have been evaluated using cynomolgus monkeys (CM) exposed to EBOV Kikwit strain. To the best of our knowledge, however, animal model development data supporting the use of CM in vaccine research have not been submitted to the FDA. This study describes a large CM database (122 CM, 62 female and 60 male, age 2 to 9 years) and demonstrates the consistency of the CM model through time to death models and descriptive statistics. CMs were exposed to EBOV doses of 0.1 to 100,000 PFU in 33 studies conducted at three Animal Biosafety Level 4 facilities, by three exposure routes. Time to death was modeled using Cox proportional hazards models with a frailty term that incorporated study-to-study variability. Despite significant differences attributed to exposure variables, all CMs exposed to the 100 to 1,000 pfu doses commonly used in vaccine studies died or met euthanasia criteria within 21 days of exposure, median 7 days, 93% between 5 and 12 days of exposure. Moderate clinical signs were observed 4 to 5 days after exposure and preceded death or euthanasia by approximately one day. Viremia was detected within a few days of infection. Hematology indices were indicative of viremia and the propensity for hemorrhage with progression of Ebola viremia. Changes associated with coagulation parameters and platelets were consistent with coagulation disruption. Changes in leukocyte profiles were indicative of an acute inflammatory response. Increased liver enzymes were observed shortly after exposure. Taken together, these factors suggest that the cynomolgus monkey is a reliable animal model for human disease.
Type of Medium:
Online Resource
ISSN:
1932-6203
DOI:
10.1371/journal.pone.0252874
DOI:
10.1371/journal.pone.0252874.g001
DOI:
10.1371/journal.pone.0252874.g002
DOI:
10.1371/journal.pone.0252874.g003
DOI:
10.1371/journal.pone.0252874.g004
DOI:
10.1371/journal.pone.0252874.g005
DOI:
10.1371/journal.pone.0252874.g006
DOI:
10.1371/journal.pone.0252874.g007
DOI:
10.1371/journal.pone.0252874.g008
DOI:
10.1371/journal.pone.0252874.g009
DOI:
10.1371/journal.pone.0252874.g010
DOI:
10.1371/journal.pone.0252874.g011
DOI:
10.1371/journal.pone.0252874.t001
DOI:
10.1371/journal.pone.0252874.t002
DOI:
10.1371/journal.pone.0252874.t003
DOI:
10.1371/journal.pone.0252874.t004
DOI:
10.1371/journal.pone.0252874.t005
DOI:
10.1371/journal.pone.0252874.t006
DOI:
10.1371/journal.pone.0252874.t007
DOI:
10.1371/journal.pone.0252874.t008
DOI:
10.1371/journal.pone.0252874.s001
DOI:
10.1371/journal.pone.0252874.s002
DOI:
10.1371/journal.pone.0252874.s003
DOI:
10.1371/journal.pone.0252874.s004
DOI:
10.1371/journal.pone.0252874.s005
DOI:
10.1371/journal.pone.0252874.s006
DOI:
10.1371/journal.pone.0252874.s007
DOI:
10.1371/journal.pone.0252874.s008
DOI:
10.1371/journal.pone.0252874.s009
DOI:
10.1371/journal.pone.0252874.s010
DOI:
10.1371/journal.pone.0252874.s011
DOI:
10.1371/journal.pone.0252874.s012
DOI:
10.1371/journal.pone.0252874.s013
DOI:
10.1371/journal.pone.0252874.s014
DOI:
10.1371/journal.pone.0252874.s015
DOI:
10.1371/journal.pone.0252874.s016
DOI:
10.1371/journal.pone.0252874.s017
DOI:
10.1371/journal.pone.0252874.s018
DOI:
10.1371/journal.pone.0252874.s019
DOI:
10.1371/journal.pone.0252874.s020
DOI:
10.1371/journal.pone.0252874.s021
DOI:
10.1371/journal.pone.0252874.s022
DOI:
10.1371/journal.pone.0252874.s023
DOI:
10.1371/journal.pone.0252874.s024
DOI:
10.1371/journal.pone.0252874.s025
DOI:
10.1371/journal.pone.0252874.s026
DOI:
10.1371/journal.pone.0252874.s027
DOI:
10.1371/journal.pone.0252874.s028
DOI:
10.1371/journal.pone.0252874.s029
DOI:
10.1371/journal.pone.0252874.s030
DOI:
10.1371/journal.pone.0252874.s031
DOI:
10.1371/journal.pone.0252874.s032
DOI:
10.1371/journal.pone.0252874.s033
DOI:
10.1371/journal.pone.0252874.s034
DOI:
10.1371/journal.pone.0252874.s035
DOI:
10.1371/journal.pone.0252874.s036
DOI:
10.1371/journal.pone.0252874.s037
DOI:
10.1371/journal.pone.0252874.s038
DOI:
10.1371/journal.pone.0252874.s039
DOI:
10.1371/journal.pone.0252874.s040
DOI:
10.1371/journal.pone.0252874.s041
DOI:
10.1371/journal.pone.0252874.s042
DOI:
10.1371/journal.pone.0252874.s043
DOI:
10.1371/journal.pone.0252874.s044
DOI:
10.1371/journal.pone.0252874.s045
DOI:
10.1371/journal.pone.0252874.s046
Language:
English
Publisher:
Public Library of Science (PLoS)
Publication Date:
2021
detail.hit.zdb_id:
2267670-3
Bookmarklink